Document is current
Any future updates will be listed below
-
Authors
McAndrews, Kathleen M. https://orcid.org/0000-0002-4092-4991
Kalluri, Raghu
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA213233, R01CA1957330, P01CA117969)
Cancer Prevention and Research Institute of Texas
- License Information
-
More Information
Article History
Received: 13 November 2018
Accepted: 20 February 2019
First Online: 30 March 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: MD Anderson Cancer Center and R. Kalluri hold patents in the area of exosome biology and are licensed to Codiak Biosciences Inc. MD Anderson Cancer Center and R. Kalluri are stock equity holders in Codiak Biosciences Inc. R. Kalluri is a consultant and a scientific advisor, and receives research support from Codiak Biosciences Inc. R. Kalluri previously served as a member of the board of directors of Codiak Biosciences.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
